1. Clark T, Maximin S, Meier J, Pokharel S, Bhargava P. Hepatocellular Carcinoma: Review of Epidemiology, Screening, Imaging Diagnosis, Response Assessment, and Treatment. Current problems in diagnostic radiology 2015;44:479-86.
2. Liu X, Li M, Wang X, et al. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma. Phytomedicine : international journal of phytotherapy and phytopharmacology 2019;62:152930.
3. McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clinics in liver disease 2015;19:223-38.
4. Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin CB. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdominal radiology (New York) 2018;43:13-25.
5. Xu XF, Xing H, Han J, et al. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China. JAMA surgery 2019;154:209-17.
6. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, Md) 2016;64:73-84.
7. Wang Y, Yu L, Ding J, Chen Y. Iron Metabolism in Cancer. International journal of molecular sciences 2018;20.
8. Chen Y, Fan Z, Yang Y, Gu C. Iron metabolism and its contribution to cancer (Review). International journal of oncology 2019;54:1143-54.
9. Hung T, Chang HY. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA biology 2010;7:582-5.
10. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes & development 2009;23:1494-504.
11. Quagliata L, Matter MS, Piscuoglio S, et al. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology (Baltimore, Md) 2014;59:911-23.
12. Bhan A, Soleimani M, Mandal SS. Long Noncoding RNA and Cancer: A New Paradigm. Cancer research 2017;77:3965-81.
13. Veatch JR, McMurray MA, Nelson ZW, Gottschling DE. Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect. Cell 2009;137:1247-58.
14. Puig S, Ramos-Alonso L, Romero AM, Martínez-Pastor MT. The elemental role of iron in DNA synthesis and repair. Metallomics : integrated biometal science 2017;9:1483-500.
15. Oexle H, Gnaiger E, Weiss G. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochimica et biophysica acta 1999;1413:99-107.
16. Miyanishi K, Tanaka S, Sakamoto H, Kato J. The role of iron in hepatic inflammation and hepatocellular carcinoma. Free radical biology & medicine 2019;133:200-5.
17. Huang C, Liang Y, Zeng X, et al. Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis. American journal of respiratory cell and molecular biology 2020;62:440-53.
18. Fan X, Liu L, Shi Y, et al. Integrated analysis of RNA-binding proteins in human colorectal cancer. World journal of surgical oncology 2020;18:222.
19. Zhou T, Gao Y. Expression of Concern to: Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma. World journal of surgical oncology 2019;17:103.
20. Chen Z, Wang X, Wang G, et al. A seven-lncRNA signature for predicting Ewing's sarcoma. PeerJ 2021;9:e11599.
21. Mehta KJ, Farnaud SJ, Sharp PA. Iron and liver fibrosis: Mechanistic and clinical aspects. World journal of gastroenterology 2019;25:521-38.
22. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (Oxford, England) 2010;26:139-40.
23. Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics : a journal of integrative biology 2012;16:284-7.
24. Fisher LD, Lin DY. Time-dependent covariates in the Cox proportional-hazards regression model. Annual review of public health 1999;20:145-57.
25. Rizvi AA, Karaesmen E, Morgan M, et al. gwasurvivr: an R package for genome-wide survival analysis. Bioinformatics (Oxford, England) 2019;35:1968-70.
26. Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC bioinformatics 2011;12:77.
27. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research 2003;13:2498-504.
28. Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. Journal of proteome research 2019;18:623-32.
29. Tirnitz-Parker JE, Glanfield A, Olynyk JK, Ramm GA. Iron and hepatic carcinogenesis. Critical reviews in oncogenesis 2013;18:391-407.
30. Li Y, Xu W, Chen P, et al. Correlation Analysis Between Preoperative Serum Iron Level and Prognosis as Well as Recurrence of HCC After Radical Resection. Cancer management and research 2020;12:31-41.
31. Rostoker G, Vaziri ND. Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution. Hemodialysis international International Symposium on Home Hemodialysis 2017;21 Suppl 1:S68-s77.
32. Kontoghiorghes GJ, Kontoghiorghe CN. Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases. Cells 2020;9.
33. Xie P, Guo Y. LINC00205 promotes malignancy in lung cancer by recruiting FUS and stabilizing CSDE1. Bioscience reports 2020;40.
34. Long X, Li Q, Zhi LJ, Li JM, Wang ZY. LINC00205 modulates the expression of EPHX1 through the inhibition of miR-184 in hepatocellular carcinoma as a ceRNA. Journal of cellular physiology 2020;235:3013-21.
35. Shahabi S, Kumaran V, Castillo J, et al. LINC00261 Is an Epigenetically Regulated Tumor Suppressor Essential for Activation of the DNA Damage Response. Cancer research 2019;79:3050-62.
36. Zhang HF, Li W, Han YD. LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma. Cancer biomarkers : section A of Disease markers 2018;21:575-82.
37. Florio M, Albert M, Taverna E, et al. Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion. Science (New York, NY) 2015;347:1465-70.
38. Li L, Lei Q, Zhang S, Kong L, Qin B. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis. Oncology reports 2017;38:2607-18.
39. Zhang Y, Qiu Z, Wei L, et al. Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma. PloS one 2014;9:e100854.
40. Qin H, Liu W. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A. Journal of cellular physiology 2019;234:3526-37.
41. Boutros R, Lobjois V, Ducommun B. CDC25 phosphatases in cancer cells: key players? Good targets? Nature reviews Cancer 2007;7:495-507.
42. Yang X, Pan Y, Qiu Z, et al. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells. Clinical cancer research : an official journal of the American Association for Cancer Research 2018;24:1629-43.
43. Gong D, Feng PC, Ke XF, et al. Silencing Long Non-coding RNA LINC01224 Inhibits Hepatocellular Carcinoma Progression via MicroRNA-330-5p-Induced Inhibition of CHEK1. Molecular therapy Nucleic acids 2020;19:482-97.
44. Sun Q, Yu R, Wang C, Yao J, Zhang L. Circular RNA circ-CSPP1 regulates CCNE2 to facilitate hepatocellular carcinoma cell growth via sponging miR-577. Cancer cell international 2020;20:202.
45. Troadec MB, Courselaud B, Détivaud L, et al. Iron overload promotes Cyclin D1 expression and alters cell cycle in mouse hepatocytes. Journal of hepatology 2006;44:391-9.
46. Sun P, Wang S, Wang J, Sun J, Peng M, Shi P. The involvement of iron in chemerin induced cell cycle arrest in human hepatic carcinoma SMMC7721 cells. Metallomics : integrated biometal science 2018;10:838-45.
47. Masaldan S, Clatworthy SAS, Gamell C, et al. Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox biology 2018;14:100-15.
48. Funauchi Y, Tanikawa C, Yi Lo PH, et al. Regulation of iron homeostasis by the p53-ISCU pathway. Scientific reports 2015;5:16497.
49. Feng Y, Feng Q, Lv Y, Song X, Qu H, Chen Y. The relationship between iron metabolism, stress hormones, and insulin resistance in gestational diabetes mellitus. Nutrition & diabetes 2020;10:17.
50. Singh AP, Fridman Y, Holland N, et al. Interdependent Nutrient Availability and Steroid Hormone Signals Facilitate Root Growth Plasticity. Developmental cell 2018;46:59-72.e4.
51. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013;153:1194-217.
52. Sfera A, Bullock K, Price A, Inderias L, Osorio C. Ferrosenescence: The iron age of neurodegeneration? Mechanisms of ageing and development 2018;174:63-75.
53. Nakamura T, Naguro I, Ichijo H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochimica et biophysica acta General subjects 2019;1863:1398-409.
54. Zhang S, Nguyen LH, Zhou K, et al. Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration. Gastroenterology 2018;154:1421-34.